Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surfactant for Neonate With ARDS
NCT03217162Unknown
- Start
- Aug 2017
- Primary completion
- Dec 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised trial of bovactant in neonatal respiratory distress syndrome (NRDS) and respiratory distress syndrome (RDS) (2 arms). Primary endpoints: Death, Bronchopulmonary dysplasia (BPD) and 1 more. Status: unknown.
02
Drugs
bovactant
03
Conditions
neonatal respiratory distress syndrome (NRDS)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT03217162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217162.